Multiple Assemblies exist for SMTL entry 3h8b
A combined crystallographic and molecular dynamics study of cathepsin-L retro-binding inhibitors(compound 9); X-RAY DIFFRACTION 1.80 Å

	SMTL ID 3h8b.1 Ligands N~2~,N~6~-bis(biphenyl-4-ylacetyl)-L-lysyl-D-arginyl-N-(2-phenylethyl)-L-phenylalaninamide Polypeptides Cathepsin L1 Oligo-state monomer
	SMTL ID 3h8b.2 Ligands N~2~,N~6~-bis(biphenyl-4-ylacetyl)-L-lysyl-D-arginyl-N-(2-phenylethyl)-L-phenylalaninamide Polypeptides Cathepsin L1 Oligo-state monomer
	SMTL ID 3h8b.3 Ligands N~2~,N~6~-bis(biphenyl-4-ylacetyl)-L-lysyl-D-arginyl-N-(2-phenylethyl)-L-phenylalaninamide Polypeptides Cathepsin L1 Oligo-state monomer
	SMTL ID 3h8b.4 Ligands N~2~,N~6~-bis(biphenyl-4-ylacetyl)-L-lysyl-D-arginyl-N-(2-phenylethyl)-L-phenylalaninamide Polypeptides Cathepsin L1 Oligo-state monomer
	SMTL ID 3h8b.5 Ligands N~2~,N~6~-bis(biphenyl-4-ylacetyl)-L-lysyl-D-arginyl-N-(2-phenylethyl)-L-phenylalaninamide Polypeptides Cathepsin L1 Oligo-state monomer
	SMTL ID 3h8b.6 Ligands N~2~,N~6~-bis(biphenyl-4-ylacetyl)-L-lysyl-D-arginyl-N-(2-phenylethyl)-L-phenylalaninamide Polypeptides Cathepsin L1 Oligo-state monomer